| HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) (NCT00106886) | Hamilton Health Sciences Corporation | 1999-12-01 |
| Vinorelbine and XR9576 to Treat Cancer (NCT00001944) | National Cancer Institute (NCI) | 1999-12-01 |
| Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation (NCT00004230) | Northwestern University | 1999-10-01 |
| Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients (NCT00199602) | University Hospital, Limoges | 1999-08-01 |
| Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients (NCT00512642) | National Institute of Environmental Health Sciences (NIEHS) | 1999-07-29 |
| Collaborative Study of 1,3 Butadiene Biomarkers (NCT00023140) | National Institute of Environmental Health Sciences (NIEHS) | 1999-07-01 |
| Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation (NCT00342966) | National Cancer Institute (NCI) | 1999-06-14 |
| Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients (NCT00003938) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-06-01 |
| Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer (NCT00273546) | Sanofi | 1999-05-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer (NCT00003704) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Promoting Healthy Lifestyles Among Firefighters (NCT00006181) | Oregon Health and Science University | 1999-04-01 |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors (NCT00003867) | Montefiore Medical Center | 1999-03-01 |
| Physicians Survey on Genetic Testing (NCT00341107) | National Cancer Institute (NCI) | 1999-02-01 |
| Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. (NCT00277004) | University of New Mexico | 1999-02-01 |
| Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation (NCT00014391) | Fred Hutchinson Cancer Center | 1999-02-01 |
| WT1 for the Detection of Minimal Residual Disease (NCT00179829) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-02-01 |
| NORVIT and WENBIT - Long-term Follow-up (NCT00671346) | Haukeland University Hospital | 1998-12-01 |
| Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors (NCT00003597) | Children's Oncology Group | 1998-11-01 |
| Selenium in the Prevention of Cancer (NCT01819649) | Odense University Hospital | 1998-11-01 |
| Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation (NCT00003883) | Fred Hutchinson Cancer Center | 1998-10-01 |
| Study of Irinotecan on a Weekly Schedule in Children (NCT00062842) | Baylor College of Medicine | 1998-09-09 |
| Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer (NCT00003439) | National Cancer Institute (NCI) | 1998-08-01 |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity (NCT00003548) | NYU Langone Health | 1998-08-01 |
| Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer (NCT00049465) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial (NCT00339495) | National Cancer Institute (NCI) | 1998-05-01 |
| Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease (NCT00806728) | MedImmune LLC | 1998-05-01 |
| A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor (NCT00001696) | National Cancer Institute (NCI) | 1998-04-01 |
| Gene Therapy in Treating Patients With Cancer (NCT00004178) | Roger Williams Medical Center | 1998-04-01 |
| Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients (NCT00481637) | Rockefeller University | 1998-03-01 |
| An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study (NCT00109057) | Genentech, Inc. | 1998-02-01 |
| Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer (NCT00003170) | Alliance for Clinical Trials in Oncology | 1998-02-01 |
| Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients (NCT00180869) | Gustave Roussy, Cancer Campus, Grand Paris | 1997-09-01 |
| Physicians' Health Study II (NCT00270647) | Brigham and Women's Hospital | 1997-07-01 |
| AIDS and Cancer Specimen Bank (ACSB) (NCT00587912) | Memorial Sloan Kettering Cancer Center | 1997-06-01 |
| Cryopreservation of Ovarian Tissue (NCT01558544) | Weill Medical College of Cornell University | 1997-04-01 |
| Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (NCT00003538) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-03-01 |
| Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures (NCT05930626) | Karolinska Institutet | 1997-01-01 |
| Pesticides--Health Fertility and Reproductive Risk (NCT00015561) | National Institute of Environmental Health Sciences (NIEHS) | 1996-09-01 |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy (NCT00270127) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1996-08-01 |
| Diabetes Prevention Program Outcomes Study (NCT00038727) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1996-07-31 |
| Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy (NCT00524407) | Ortho Biotech, Inc. | 1996-07-01 |
| A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons (NCT00340015) | National Cancer Institute (NCI) | 1995-10-24 |
| Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation (NCT00002673) | Fred Hutchinson Cancer Center | 1995-06-01 |
| Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study (NCT00342992) | National Cancer Institute (NCI) | 1995-03-03 |
| Childhood Cancer Survivor Study (NCT01120353) | St. Jude Children's Research Hospital | 1995-01-05 |
| Essential Hypotension and Allostasis Registry (NCT02018497) | CES University | 1995-01-01 |
| Cologne Cohort of Neutropenic Patients (CoCoNut) (NCT01821456) | University Hospital of Cologne | 1995-01-01 |
| 102 Annual Pap Smear Screening Database Maintenance Project (NCT02063152) | National Taiwan University Hospital | 1995-01-01 |
| High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer (NCT00002854) | City of Hope Medical Center | 1994-12-01 |
| Evaluation and Natural History of Children With Cancer and AIDS (NCT00001424) | National Cancer Institute (NCI) | 1994-11-01 |
| Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study (NCT00250809) | University of New Mexico | 1994-03-01 |
| A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 (NCT00001383) | National Cancer Institute (NCI) | 1994-03-01 |
| The Singapore Chinese Health Study (NCT03356340) | Duke-NUS Graduate Medical School | 1993-04-01 |
| Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease (NCT00001295) | National Cancer Institute (NCI) | 1992-01-29 |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia (NCT00270049) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1990-11-01 |
| Fernald Community Cohort -18 Year Observational Study (NCT02295085) | University of Cincinnati | 1990-09-01 |
| Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer (NCT00269763) | Alza Corporation, DE, USA | 1987-10-01 |
| Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer (NCT00269737) | Alza Corporation, DE, USA | 1986-05-01 |
| Northern Sweden Health and Disease Study (NCT03426488) | Umeå University | 1986-01-01 |
| Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer (NCT00001163) | National Cancer Institute (NCI) | 1985-04-02 |
| Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study (NCT02991105) | University of Birmingham | 1985-01-01 |
| Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) (NCT03221127) | University of Eastern Finland | 1984-03-01 |
| Examining the Long-Term Risks of Oophorectomy (NCT00655447) | Parker, William H., M.D. | 1980-01-01 |
| Suicide Risk Prediction in Cancer Patients (NCT06167720) | Fang Tang | 1979-01-01 |
| The Copenhagen City Heart Study (NCT02993172) | Bispebjerg Hospital | 1976-01-01 |
| Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study (NCT03410641) | Oslo University Hospital | 1972-01-15 |
| ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer (NCT00034463) | Eli Lilly and Company | |
| Low Levels of Electromagnetic Fields to Treat Advanced Cancer (NCT00805337) | Pasche, Boris, M.D. | |
| Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours (NCT01194193) | AstraZeneca | |
| Enteral Nutrition in Cancer Patients (NCT01304446) | Grupo de Apoio ao Adolescente e a Crianca com Cancer | |
| Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884) (NCT05572970) | Agenus Inc. | |
| Biomarkers of Benzene Exposure in Inner City Residents (NCT00014963) | National Institute of Environmental Health Sciences (NIEHS) | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain (NCT00002160) | Neurex | |
| Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy (NCT00111462) | Amgen | |
| Enteral Nutrition in Cancer Patient (NCT01302509) | Grupo de Apoio ao Adolescente e a Crianca com Cancer | |
| Implementation of Physical Cancer Rehabilitation Programmes in a European Healthcare System. (NCT02205853) | Radboud University Medical Center | |
| (Bispecific) Antibodies in Cancer Patients (NCT05119257) | University Hospital Tuebingen | |
| Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation (NCT06761976) | Bayer | |
| Hematotoxic Effects of Particulate Exposure (NCT00015483) | National Institute of Environmental Health Sciences (NIEHS) | |
| Diagnosis of Cancer Using Breath Samples (NCT01234987) | Technion, Israel Institute of Technology | |
| MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer (NCT06980519) | Monopar Therapeutics | |
| Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors (NCT06238583) | Bayer | |
| Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors (NCT06963697) | Jaime Leandro Foundation for Therapeutic Cancer Vaccines | |
| Master Rollover Protocol for Continued Safety Assessment of Study Drug (NCT02632994) | Eli Lilly and Company | |
| Expanded Access to VAL-083 (NCT03138629) | Kintara Therapeutics, Inc. | |
| Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer (NCT04869501) | I-Mab Biopharma US Limited | |
| MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer (NCT06980506) | Monopar Therapeutics | |
| Modulation of Benzene Metabolism by Exposure to Environment (NCT00041860) | National Institute of Environmental Health Sciences (NIEHS) | |
| A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy (NCT00119600) | Amgen | |
| Association Between Schizophrenia and Cancer (NCT00419016) | Sheba Medical Center | |
| Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients (NCT05014607) | University Hospital Tuebingen | |
| A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer (NCT00105651) | US Department of Veterans Affairs | |
| Expanded Access for PSV Personalized Oncolytic Viruses (NCT03529539) | EpicentRx, Inc. | |
| Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection (NCT00378781) | M.D. Anderson Cancer Center | |
| Nevada Environmental Tobacco Smoke and Health Study (NCT00046306) | National Institute of Environmental Health Sciences (NIEHS) | |
| Transcriptomal and Molecular Characterization of Tumor Associated Monocytes/Macrophages in Human Cancers (NCT00979277) | National University Hospital, Singapore | |
| Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak) (NCT01432483) | Eisai Inc. | |
| Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32) (NCT00006199) | National Center for Research Resources (NCRR) | |
| Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer (NCT01786850) | University of Roma La Sapienza | |